To visit the old Ventura website, click here.
Ventura Wealth Clients
2 min Read

Zaynich’s success drives Wockhardt stock up by 10%

Wockhardt shares gained 10% after the company announced that its flagship discovery product, Zaynich, achieved 96.8% efficacy in a phase III study for complicated urinary...

By Ventura Research Team